BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 759804)

  • 1. [Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
    Loew D
    Med Welt; 1979 Feb; 30(5):166-9. PubMed ID: 759804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
    Ostendorf P
    Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
    Schöndorf TH
    Med Welt; 1982 Jun; 33(23):851-4. PubMed ID: 7050615
    [No Abstract]   [Full Text] [Related]  

  • 6. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
    Boeynaems JM
    Rev Med Brux; 1982 Jun; 3(6):415-24. PubMed ID: 7111939
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment and prevention of thromboembolism with anti-aggregation drugs].
    Donner L
    Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary prevention of peripheral arterial occlusive diseases].
    Bollinger A
    Ther Umsch; 1987 Sep; 44(9):682-5. PubMed ID: 2960028
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aggregation inhibitors or anticoagulants in the prevention of peripheral arterial occlusive diseases].
    Loew D; Hess H
    Med Welt; 1982 Oct; 33(43):1511-5. PubMed ID: 6759847
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA; Savenkov MP
    Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H
    Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is modern anti-aggregation therapy effective?].
    Hladovec J
    Cas Lek Cesk; 1984 May; 123(21):630-5. PubMed ID: 6744376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
    Loew D; Breddin K; Uberla K
    MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.